For citations:
Ananyeva L.P., Koneva O.A., Desinova O.V., Garzanova L.A., Glukhova S.I., Starovoitova M.N., Ovsyannikova O.B., Volkov A.V., Aleksankin A.P., Nasonov E.L. Effect of rituximab on the manifestations of activity and pulmonary function in patients with systemic sclerosis: one-year follow-up evaluation. Rheumatology Science and Practice. 2019;57(3):265-273. (In Russ.) https://doi.org/10.14412/1995-4484-2019-265-273
Email this article 